As abnormal renal epithelial cell proliferation in ADPKD is associated with cAMP-induced activation of the B-Raf/MEK/ERK pathway [24], we attempted to examine whether the treatment with PAC+ATRA affects the MEK/ERK pathway and consequently controls ADPKD epithelial cell growth. Here, BRAF is linked to autosomal dominant polycystic kidney disease.